Abstract
The presence of one or more elements of chirality (i.e., centers, axes or planes of chirality, and generally helicity) (Cahn et al. 1966; Testa 1979) in drug molecules generates specific properties which may be advantageous in some cases, but inevitably require special consideration and studies. Examples of advantages include the possibility of increased selectivity and the fact that chirality per se is an invaluable probe in molecular pharmacology and biochemistry (Testa 1989,1990; Testa and Trager 1990). In contrast, problems generated by stereoisomerism include the need for stereospecific synthetic and analytical methods, the influence of the degree of resolution on activity (Barlow et al. 1972), and the increased complexity of metabolic, pharmacological, and clinical studies (AriËns 1986; Testa et al. 1993a).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Allenmark S (1991) Chromatographic Enantioseparation: Methods and Applications. Ellis Horwood, London
Ariens EJ (1986) Stereochemistry: a source of problems in medicinal chemistry. Med Res Rev 6:451–466
Aso Y, Yoshioka S, Shibazaki T, Uchiyama M (1988) The kinetics of the racemization of oxazepam in aqueous solution. Chem Pharm Bull 36:1834–1840
Barlow RB, Franks FM, Pearson JDM (1972) The relation between biological activity and the degree of optical resolution of optical isomers. J Pharm Pharmacol 24: 753–761
Beckmann R (1963) Ueber das Verhalten von Thalidomid im Organismus. Arzneim-Forsch 13:185–191
Cahn RS, Ingold C, Prelog V (1966) Specification of molecular chirality. Angew Chem Int Ed 5:385–415
Chen TL, Vogelsang GB, Petty BG, Brundrett RB, Noe DA, Santos GW, Colvin OM (1989) Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers. Drug Metab Dispos 17:402–405
Coward JK, Bruice TC (1969) Intramolecular amine-catalyzed ketone enolization. A search for concerted intramolecular general-base, general-acid catalysis. J Am Chem Soc 91:5339–5345
Cram DJ, Cram JM (1973) Carbanions and carbonium ions—stereochemical analogs. Intra Science Chem Rep 7:1–17
Cram DJ, Kingsbury CA, Rickborn B (1961) Electrophilic substitution at saturated carbon. XIV. Asymmetric solvation of carbanions in stereospecific hydrogendeuterium exchange reactions. J Am Chem Soc 83:3688–3696
Eriksson T, Björkman S, Roth B, Fyge A, Höglund P (1995) Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide. Chirality 7:44–52
Gu L, Strickley RG (1987) Diketopiperazine formation, hydrolysis, and epimerization of the new dipeptide angiotensin-converting enzyme inhibitor RS-10085. Pharm Res 4:392–397
Hoffmann K, Schneider-Scherzer E, Kleinkauf H, Zocher R (1994) Purification and characterization of eucaryotic alanine racemase acting as key enzyme in cyclosporin biosynthesis. J Biol Chem 269:12710–12714
Holmberg B (1913) Stereochemie der halogensubstituierten Bernsteinsäuren. J Prakt Chem 88:553–603
Hsü SK, Wilson CL (1936) Optical activity in relation to tautomeric change. Part VI. Comparison of the rates of racemization and of bromination of a ketone. A Further study under conditions of basic catalysis. J Chem Soc 623–625
Hsü SK, Ingold CK, Wilson CL (1938) Prototropy in relation to the exchange of hydrogen isotopes. Part III. Comparison of the rates of racemization and of hydrogen exchange in α-acidic ketone. J Chem Soc 78–81
Ingold CK, Wilson CL (1934) Optical activity in relation to tautomeric change. Part IV. Comparison of the rates of racemization and of bromination of a ketone. J Chem Soc 773–777
Kawazoe Y, Ohnishi M (1964) Quantitative analysis of active hydrogen by nuclear magnetic resonance. Chem Pharm Bull 11:846–848
Knoche B, Blaschke G (1994) Investigations on the in vitro racemization of thalidomide by high-performance liquid chromatography. J Chromatogr 666:235–240
Koch H (1981) Die Arenoxid-Hypothese der Thalidomid-Wirkung. Ueberlegungen zum molekularen Wirkungsmechanismus des “klassischen” Teratogens. Sci Pharm 49:67–99
Lickefett H, Krohn K, König WA, Gehrcke B, Syldatk C (1993) Enantioseparation of 5-monosubstituted hydantoins by capillary gas chromatography—investigation of chemical and enzymatic racemization. Tetrahedron Asym 4:1129–1135
March J (1985) Advanced Organic Chemistry. Wiley, New York, pp 512–575
Matsuo H, Kawazoe Y, Sato M, Ohnishi M, Tatsuno T (1967) Studies on the racemization of amino acids and their derivatives. I. On the deuterium-hydrogen exchange reaction of amino acid derivatives in basic media. Chem Pharm Bull 15:391–398
Mayer JM (1990) Stereoselective metabolism of antiinflammatory 2-arylpropionates. Acta Pharm Nord 2:197–216
Mayer JM, Young M, Testa B, Etter JC (1989) Modelling the metabolic epimerization of antiinflammatory 2-arylpropanoyl-coenzyme-A conjugates: solvent effects on the 1H/2H exchange in S-[2-(dimethylamino)ethyl] 2-phenylpropanethioate. Helv Chim Acta 72:1225–1232
Mellin GW, Katzenstein M (1962) The saga of thalidomide: neuropathy to embryopathy, with case reports and congenital anomalies. N Eng J Med 267:1184–1244
Mitra B, Kallarakal AT, Kozarich JW, Gerlt JA, Clifton JG, Petsko GA, Kenyon GL (1995) Mechanism of the reaction catalyzed by mandelate racemase: importance of electrophilic catalysis by glutamic acid 317. Biochemistry 34:2777–2787
Moreira AL, Corral LG, Ye W, Johnson B, Stirling D, Muller GW, Freedman VH, Kaplan G (1997) Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro. AIDS Res Hum Retrov 13:857–863
Nunes MA, Brochmann-Hanssen E (1974) Hydrolysis and epimerization kinetics of pilocarpine in aqueous solution. J Pharm Sci 63:716–721
Ockenfels H, Köhler F, Meise W (1976) Teratogenic effect and stereospecificity of a thalidomide metabolite. Pharmazie 31:492–493
Peters Jr T (1996) All about Albumin. Biochemistry, Genetics, and Medical Applications. Academic Press, San Diego, pp 9–75
Rama Sastry BV (1981) Anticholinergics: antispasmodic and antiulcer drugs. In: Wolff ME (ed) Burger’s Medicinal Chemistry, Fourth Edition, Part III. Wiley, New York, p 371
Reist M, Testa B, Carrupt PA, Jung M, Schurig V (1995a) Racemization, enantiomerization, diastereomerization, and epimerization: their meaning and pharmacological significance. Chirality 7:396–400
Reist M, Christiansen LH, Christoffersen P, Carrupt PA, Testa B (1995b) Low configurational stability of amfepramone and cathinone: mechanism and kinetics of chiral inversion. Chirality 7:469–473
Reist M, Carrupt PA, Testa B, Lehmann S, Hansen JJ (1996) Kinetics and mechanisms of racemization: 5-substituted hydantoins (= imidazoline-2,4-diones) as models of chiral drugs. Helv Chim Acta 79:767–778
Reist M, Testa B, Carrupt PA (1997) The racemization of enantiopure drugs: helping medicinal chemists to approach the problem. Enantiomer 2:147–155
Reist M, Carrupt PA, Francotte E, Testa B (1998) Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites. Chem Res Toxicol 11:1521–1528
Reist M, Roy-de Vos M, Montseny JP, Mayer JM, Carrupt PA, Berger Y, Testa B (2000) Very slow chiral inversion of Clopidogrel in rats: a pharmacokinetic and mechanistic investigation. Drug Metal Disposit 28:1405–1410
Roitman JN, Cram DJ (1971) Electrophilic substitution at saturated carbon. XLV. Dissection of mechanisms of base catalyzed hydrogen-deuterium exchange of carbon acids into inversion, isoinversion, and racemization pathways. J Am Chem Soc 93:2225–2243
Sanders JKM, Hunter BK (1993) Modern NMR Spectroscopy: a Guide for Chemists. Oxford University Press, Oxford, pp 33–52
Schmitz W, Albers C, Fingerhut R, Conzelmann E (1995) Purification and characterization of an alpha-methylacyl-CoA racemase from human liver. Eur J Biochem 231:815–822
Schumacher H, Smith RL, Williams RT (1965a) The metabolism of thalidomide: the fate of thalidomide and some of its hydrolysis products in various species. Br J Pharmacol 25:338–351
Schumacher H, Smith RL, Williams RT (1965b) The metabolism of thalidomide: the spontaneous hydrolysis of thalidomide in solution. Br J Pharmacol 25:324–337
Shannon EJ, Morales EJ, Sandoval F (1997) Immunomodulatory assays to study structure-activity relationships of thalidomide. Immunopharmacology 35:203–212
Sheskin J (1965) Thalidomide in the treatment of lepra reactions. Clin Pharmacol Ther 6:303–306
Stevens RJ, Andujar C, Edwards CJ, Ames PR, Barwick AR, Khamashta MA, Hughes GR (1997) Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol 36:353–359
Testa B (1973) Some chemical and stereochemical aspects of diethylpropion metabolism in man. Acta Pharm Suec 10:441–454
Testa B (1979) Principles of Organic Stereochemistry. Dekker, New York
Testa B (1989) Mechanisms of chiral recognition in xenobiotic metabolism and drugreceptor interactions. Chirality 1:7–9
Testa B (1990) Definitions and concepts in biochirality. In: Holmstedt B, Frank H, Testa B (eds) Chirality and Biological Activity. Liss, New York, pp 15–32
Testa B (1995) The Metabolism of Drugs and other Xenobiotics—Biochemistry of Redox Reactions. Academic Press, London
Testa B, Jenner P (1976) Drug Metabolism: Chemical and Biochemical Aspects. Dekker, New York
Testa B, Jenner P (1978) Stereochemical methodology. In: Garrett ER, Hirtz JL (eds) Drug Fate and Metabolism: Methods and Techniques. Dekker, New York, pp 143–193
Testa B, Trager WF (1990) Racemates versus enantiomers in drug development: dogmatism or pragmatism? Chirality 2:129–133
Testa B, Carrupt PA, Christiansen LH, Christoffersen P, Reist M (1993a) Chirality in drug research: stereomania, stereophobia, or stereophilia? In: Ciaassen V (ed) Trends in Receptor Research. Elsevier, Amsterdam, pp 1–8
Testa B, Carrupt PA, Gal J (1993b) The so-called “interconversion” of stereoisomeric drugs: an attempt at clarification. Chirality 5:105–111
Tokuyama S, Hatano K (1995) Purification and properties of thermostable N- acylamino acid racemase from Amycolatopsis sp. TS-1-60. Applied Microbiol Biotechnol 42:853–859
Vogelsang GB, Farmer ER, Hess AD, Altamonte V, Beschorner WE, Jabs DA, Corio RL, Levin LS, Colvin OM, Wingard JR (1992) Thalidomide for the treatment of chronic graft-versus-host disease. N Eng J Med 326:1055–1058
Werner A (1911) Ueber den räumlichen Stellungswechsel bei Umsetzungen von raumisomeren Verbindungen. Berichte 44:873–882
Yagasaki M, Iwata K, Ishino S, Azuma M, Ozaki A (1995) Cloning, purification, and properties of a cofactor-independent glutamate racemase from Lactobacillus brevis ATCC 8287. Biosci Biotechnol Biochem 59:610–614
Yamauchi T, Choi SY, Okada H, Yohda M, Kumagai H, Esaki N, Soda K (1992) Properties of aspartate racemase, a pyridoxal 5’-phosphate-independent amino acid racemase. J Biol Chem 267:18361–18364
Zini R, Barré J, Brée F, Tillement JP, Sébille B (1981) Evidence for a concentration-dependent polymerization of a commercial human serum albumin. J Chromatogr 216:191–198
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Reist, M., Testa, B., Carrupt, PA. (2003). Drug Racemization and Its Significance in Pharmaceutical Research. In: Eichelbaum, M., Testa, B., Somogyi, A. (eds) Stereochemical Aspects of Drug Action and Disposition. Handbook of Experimental Pharmacology, vol 153. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55842-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-55842-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62575-6
Online ISBN: 978-3-642-55842-9
eBook Packages: Springer Book Archive